Reporting Octaplas SAR and SAE

Octaplas is a sterile, frozen solution of pooled human plasma from several donors that has been treated with a solvent detergent process. Octaplas is a manufactured blood product, as such all serious adverse reactions should be reported to the MHRA via the yellow card scheme, as with all other blood products. In addition to this SHOT accept SAR and SAE relating to Octaplas.

Full SHOT reporting definitions (including the limited blood products SHOT accepts reports regarding) can be found at https://www.shotuk.org/wp-content/up...d-Feb-2021.pdf

Any queries please contact shot@nhsbt.nhs.uk